Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca S Belli

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 13, 2020
Liver Transplantation in Acute-on-Chronic Liver Failure Is a Wise Longterm InvestmentJonel Trebicka, Luca S Belli
The New England Journal of Medicine|December 14, 2016
Treatment of Patients with CirrhosisGiovanni Perricone, Marcello Vangeli, Luca S Belli
Gastroenterology|April 23, 2021
ReplyLuca S Belli, Sara Conti, Wojciech Polak
The New England Journal of Medicine|August 27, 2020
Acute-on-Chronic Liver FailureGiovanni Perricone, Andrea Mancuso, Luca S Belli
Journal of Hepatology|November 8, 2022
Attitudes toward liver transplantation for ACLF-3 determine equity of accessThierry Artzner, Luca S Belli, François Faitot, et al.
Journal of Hepatology|September 6, 2017
Direct-acting antiviral therapy in patients with hepatocellular cancer: The timing of treatment is everythingChiara Mazzarelli, Mary D Cannon, Luca S Belli, et al.
European Journal of Gastroenterology & Hepatology|April 4, 2014
Sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation: does mTOR inhibitors association augment toxicity?Giovanni Perricone, Andrea Mancuso, Luca S Belli, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 28, 2003
Tapering off steroids three months after liver transplantation is not detrimental for hepatitis C virus disease recurrenceLuca S Belli, Alberto B Alberti, Marcello Vangeli, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 10, 2020
Reply to Rodriguez-Peralvarez et alWojciech G Polak, Constantino Fondevila, Vincent Karam, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 6, 2018
Palliative care in end-stage liver disease: Time to do better?Chiara Mazzarelli, Wendy M Prentice, Michael A Heneghan, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 13, 2020
Liver Transplantation in Acute-on-Chronic Liver Failure Is a Wise Longterm InvestmentJonel Trebicka, Luca S Belli
The New England Journal of Medicine|December 14, 2016
Treatment of Patients with CirrhosisGiovanni Perricone, Marcello Vangeli, Luca S Belli
Gastroenterology|April 23, 2021
ReplyLuca S Belli, Sara Conti, Wojciech Polak
The New England Journal of Medicine|August 27, 2020
Acute-on-Chronic Liver FailureGiovanni Perricone, Andrea Mancuso, Luca S Belli
Journal of Hepatology|November 8, 2022
Attitudes toward liver transplantation for ACLF-3 determine equity of accessThierry Artzner, Luca S Belli, François Faitot, et al.
Journal of Hepatology|September 6, 2017
Direct-acting antiviral therapy in patients with hepatocellular cancer: The timing of treatment is everythingChiara Mazzarelli, Mary D Cannon, Luca S Belli, et al.
European Journal of Gastroenterology & Hepatology|April 4, 2014
Sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation: does mTOR inhibitors association augment toxicity?Giovanni Perricone, Andrea Mancuso, Luca S Belli, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 28, 2003
Tapering off steroids three months after liver transplantation is not detrimental for hepatitis C virus disease recurrenceLuca S Belli, Alberto B Alberti, Marcello Vangeli, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 10, 2020
Reply to Rodriguez-Peralvarez et alWojciech G Polak, Constantino Fondevila, Vincent Karam, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 6, 2018
Palliative care in end-stage liver disease: Time to do better?Chiara Mazzarelli, Wendy M Prentice, Michael A Heneghan, et al.
Pageof 4